US Patent Issued to Arvinas Operations on Dec. 16 for "Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy" (Connecticut Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,301, issued on Dec. 16, was assigned to Arvinas Operations Inc. (New Haven, Conn.).

"Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy" was invented by Dan Sherman (Madison, Conn.) and James Alan Gregory (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure pertains to methods of treating or preventing spinal and bulbar muscular atrophy (SBMA), or one or more symptoms of SBMA, wherein the method comprises administering to a subject in need thereof an effective amount of Compound A, or a pharmaceutically acceptable salt thereof."

The patent was filed on Dec. 6, 2024, under Applicatio...